34. CBER director Peter Marks said @US_FDA is looking at making another vaccine available. He said @CDCgov (through #ACIP) might do this.
FDA's Doran Fink said the J&J decision was based on the serious safety concern, TTS, which is associated with it.

— Helen Branswell 🇨🇦 (@HelenBranswell) June 7, 2022